Properties and Activities of Phosphoribomutase in Human Leukemic Cells

  • Y. Nishida
  • N. Kamatani
  • T. Miyamoto
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 165)


The enzyme phosphoribomutase acts on the conversion of ribose-1-phosphate (R-1-P) to ribose-5-phosphate (R-5-P) (1). R-5-P is a substrate of phosphoribosyl-pyrophosphate (PRPP) synthetase, The R-5-P and PRPP pool in the cell has been shown to be small (2). R-l-P is liberated from purine nucleosides by the action of purine nucleoside Phosphorylase. Therefore, it seems that phosphoribomutase is an important enzyme in the reutilization of ribose from purine nucleosides and in the formation of PRPP. We have measured the activity of phosphoribomutase in human leukemic cells and the properties of this enzyme in leukemic cells were also studied.


Leukemic Cell Human Leukemic Cell Purine Nucleoside Purine Nucleoside Phosphorylase Adenine Phosphoribosyltransferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. Hershko, A. Razin, and J. Mager, Regulation of the synthesis of 5-phosphoribosyl-pyrophosphate in intact red blood cells and in cell-free preparations. Biochem. Biophys. Acta. 184: 64 (1969).PubMedCrossRefGoogle Scholar
  2. 2.
    M. A. Becker, Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. J. Clin. Invest. 57: 208 (1976).CrossRefGoogle Scholar
  3. 3.
    Y. Nishida, I. Akaoka, and Y. Horiuchi, Altered isoelectric property of a superactive 5-phosphoribosyl-1-pyrophosphate synthetase in a patient with clinical gout. Biochem. Med. 26: 387 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    C. B. Thomas, W. J. Arnold, and W. N. Kelley, Human adenine phosphoribosyltransferase. Purification, subunit, structure, and substrate specificity. J. Biol. Chem. 248: 2529 (1973).PubMedGoogle Scholar
  5. 5.
    I. H. Fox, and W. N. Kelley, Human phosphoribosylpyrophosphate synthetase. Distribution, purification and properties. J. Biol. Chem. 246: 5739 (1971).PubMedGoogle Scholar
  6. 6.
    O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265 (1951)PubMedGoogle Scholar
  7. 7.
    A. Boyum, Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21: Supp. 97 (1968).Google Scholar
  8. 8.
    A. Takeuchi, and R. Persellin, Cellular augmentation of polymorphonuclear leukocyte chemotoxis. Amer. J. Physiol. 236: C22 (1974)Google Scholar
  9. 9.
    H. Haglund, Isoelectric focussing in pH gradients. A technique for fractionation and characterization of ampholytes. Meth. Biochem. Anal. 19: 1 (1971).CrossRefGoogle Scholar
  10. 10.
    T. Higuchi, T. Nakamura, and G. Wakisaka, The formation of 5-phosphoribosyl-1-pyrophosphate in human leukemic leukocytes. Biochem. Med. 13: 178 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    M. K. Danks, and E. M. Scholar, Comparison of the properties of phosphoribosyl-pyrophosphate synthetase in normal and leukemic human white blood cells. Biochem. Pharm. 28: 2733 (1979).PubMedCrossRefGoogle Scholar
  12. 12.
    I. H. Fox, and W. N. Kelley, Phosphoribosyl-1-pyrophosphate in man. Biochemical and clinical significance. Ann. Int. Med. 74: 424 (1971).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Y. Nishida
    • 1
  • N. Kamatani
    • 1
  • T. Miyamoto
    • 1
  1. 1.Department of Medicine and Physical Therapy Faculty of MedicineUniversity of TokyoBunkyo-ku, TokyoJapan

Personalised recommendations